Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Kiplingers published an article in the June issue on Buffered/Defined Outcome ETFs such as BJAN, BFEB, BMAR, etc. The main players listed are Innovator, First Trust, AllianzIM and TrueShares.
Read the fine print VERY closely and also beware of counterparty risk, both of which plagued these things back in 2008 and led to many shareholder lawsuits against the big banks. At least with structured notes that did this during the mid-00s, how they calculate buffers and what happens if the markets close even *once* outside that line might make a big difference in whether you get all the expected returns or just your original money back.
ETFs might be better than structured notes here, though I've not looked into them. Either way, do your homework and again, read the fine print.
Comments
ETFs might be better than structured notes here, though I've not looked into them. Either way, do your homework and again, read the fine print.